Applied Biosystems Announces Commercial Availability Of Rapid Avian Influenza Detection Kits In Europe, Asia And Africa

WARRINGTON, England--(BUSINESS WIRE)--March 13, 2006--Assay Can Be Run on More Than 1,400 Applied Biosystems Instruments in Public Health Laboratories across Europe, Asia and Africa. Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the commercial availability in Europe, Asia, and Africa of its TaqMan(R) Influenza A/H5 Detection Kit, which is capable of rapidly and reliably detecting multiple strains of avian influenza in laboratory samples. This test is not currently available for sale in the United States.

MORE ON THIS TOPIC